Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37098132)
Watch
English
Gemcitabine and taxanes in metastatic breast cancer: a systematic review.
scientific article published on December 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Gemcitabine and taxanes in metastatic breast cancer: a systematic review
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
main subject
systematic review
1 reference
based on heuristic
inferred from title
metastatic breast cancer
1 reference
based on heuristic
inferred from title
author name string
Vinay Gudena
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
Alberto J Montero
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
Stefan Glück
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
publication date
1 December 2008
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
published in
Therapeutics and Clinical Risk Management
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
volume
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
issue
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
page(s)
1157-1164
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
cites work
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Cancer statistics, 2008
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Role of gemcitabine in metastatic breast cancer patients: a short review
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Dose-dense adjuvant chemotherapy for primary breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
29 September 2017
Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
27 June 2018
Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
3 September 2018
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643097
retrieved
4 December 2018
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19337423
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19337423
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Action of 2',2'-difluorodeoxycytidine on DNA synthesis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19337423
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMC publication ID
2643097
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
PubMed publication ID
19337423
1 reference
stated in
Europe PubMed Central
PMC publication ID
2643097
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337423%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit